Publication | Closed Access
Characterization of the muscarinic receptor subtype mediating vasodilation in the rat perfused mesenteric vascular bed preparation
24
Citations
25
References
1992
Year
HypertensionMuscarinic Receptor SubtypeCardiovascular PharmacologyPharmacotherapyExperimental PharmacologyLow PotencyPharmacodynamic ModelingMolecular PharmacologyHigh PotencyAnesthetic PharmacologyResistance VesselsMolecular PhysiologyVascular PharmacologyReceptor (Biochemistry)Vascular BiologyBeta-adrenergic PharmacologyPharmacologyCardiovascular DiseasePhysiologyEndothelial DysfunctionClinical PharmacologyMedicine
1. The nature of the muscarinic receptor subtype mediating endothelium-dependent vascular relaxation was investigated in the perfused mesenteric vascular bed preparation which is a model for resistance vessels. 2. After methoxamine-induced vasoconstriction the vessels were dilated with acetyl-beta-metacholine (MCh). 3. The potency of the M1-selective antagonist pirenzepine, the M2-selective antagonists AF-DX 116 and AQ-RA 741, the M3-selective antagonists 4-DAMP and p-FHHSiD to block the MCh-induced vasodilation was quantified by means of pA2-values. Atropine was used for comparison. 4. The rank order of potency for the various muscarinic receptor antagonists appears to be: atropine > 4-DAMP > p-FHHSiD > pirenzepine > AQ-RA 741 > AF-DX 116 which is similar to findings in conduit arteries. 5. The high potency of the M3-selective antagonists 4-DAMP and p-FHHSiD and the low potency of the M1- and M2-selective antagonists suggest a major role of M3-receptors in the cholinergic vasodilatation in the perfused mesenteric vascular bed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1